Skip Navigation



JAC Advance Access published online on June 11, 2007
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm210
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/2/356    most recent
dkm210v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Matthews, P. C.
Right arrow Articles by Byren, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthews, P. C.
Right arrow Articles by Byren, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years

Philippa C. Matthews1,2,*, Christopher P. Conlon1, Anthony R. Berendt1,2, Jill Kayley3, Lorrayne Jefferies4, Bridget L. Atkins1,2 and Ivor Byren1,2

1 Oxford Radcliffe Hospitals NHS Trust, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK 2 Bone Infection Unit, Nuffield Orthopaedic Centre NHS Trust, Windmill Road, Headington, Oxford OX3 7LD, UK 3 The Pavilion, Thames Road, Goring on Thames, Reading, Berkshire RG8 9AH, UK 4 Oxfordshire Primary Care Trust, Unit 1, Isis Business Park, Pony Road, Oxford OX4 2RD, UK

Received 19 February 2007; returned 10 April 2007; revised 16 May 2007; accepted 17 May 2007

* Corresponding author. Tel: +44-1865-738029; Fax: +44-1865-227694; E-mail: p.matthews{at}doctors.org.uk

Objectives: Provision of outpatient parenteral antimicrobial therapy (OPAT) is an evolving field, facilitating discharge from hospital for selected patients with serious infections. We report on a large OPAT cohort focusing on the practice of supervised parenteral antibiotic administration in the community by patients and relatives, which we collectively term ‘self-administration’. To distinguish between healthcare professional OPAT and self-administered OPAT, we have coined the terms H-OPAT and S-OPAT, respectively.

Patients and methods: We analysed data on 2059 OPAT episodes collected prospectively over a 13 year time period from 1993 to 2005.

Results: Clinical diagnosis, microbiology and antibiotics in this OPAT series are comparable to those previously reported. We identified no excess complications or hospital re-admissions in the S-OPAT group compared with the H-OPAT group.

Conclusions: Self-administration of intravenous antimicrobial therapy, in selected patients under the supervision of a specialist team, is a safe and feasible strategy.

Key Words: home intravenous therapy , H-OPAT , S-OPAT , self-administration , complications


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
D. Nathwani
Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin
J. Antimicrob. Chemother., September 1, 2009; 64(3): 447 - 453.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Coenen, A. Muller, N. Adriaenssens, V. Vankerckhoven, E. Hendrickx, H. Goossens, and on behalf of the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe
J. Antimicrob. Chemother., July 1, 2009; 64(1): 200 - 205.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. Byren, P. Bejon, B. L. Atkins, B. Angus, S. Masters, P. McLardy-Smith, R. Gundle, and A. Berendt
One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome
J. Antimicrob. Chemother., June 1, 2009; 63(6): 1264 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
P. C Matthews, A. R Berendt, M. A McNally, and I. Byren
Diagnosis and management of prosthetic joint infection
BMJ, May 29, 2009; 338(may29_1): b1773 - b1773.
[Full Text]

Home page
 J Antimicrob ChemotherHome page
S. Rehm, M. Campion, D. E. Katz, R. Russo, and H. W. Boucher
Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy
J. Antimicrob. Chemother., May 1, 2009; 63(5): 1034 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. R. Ingram, Z. Sulaiman, A. Chua, and D. A. Fisher
Comment on: Outpatient parenteral antibiotic therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years
J. Antimicrob. Chemother., January 1, 2008; 61(1): 226 - 227.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.